Sponsor or institution
Clinical trials and research at Neuromed IRCCS
As of November 12, 2026, Find a Trial lists 6 clinical trials run by Neuromed IRCCS that are recruiting, in Italy. 1 was first registered in the last 30 days. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1New in 30 days
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Diabetes, Dementia, and Oxidative Stress: A look at Nox2-related markers | — | Pozzilli | Recruiting | Nov 10, 2026 |
| Precision medicine approach for diagnosing and treating Parkinson's, Alzheimer's, and type 2 diabetes | — | Pozzilli | Recruiting | Mar 12, 2026 |
| Identifying protein biomarkers in biofluids for neurodegenerative disorders | — | Pozzilli, Italy | Recruiting | Jan 31, 2025 |
| Understanding Inhibitory Neurotransmission in Drug-Resistant Epilepsy | — | Pozzilli, Isernia | Recruiting | Jul 14, 2022 |
| Effects of the Mediterranean diet on pregnancy and fetal development | — | Agropoli, SA | Recruiting | Jun 3, 2022 |
| Identifying biomarkers of synaptic damage in multiple sclerosis | — | Pozzilli, Isernia | Recruiting | Jul 14, 2017 |
All recruiting trials (6)
-
Diabetes, Dementia, and Oxidative Stress: A look at Nox2-related markers
This study tests whether oxidative stress linked to Nox2 is related to dementia risk in adults with type 2 diabetes.
-
Precision medicine approach for diagnosing and treating Parkinson's, Alzheimer's, and type 2 diabetes
This project will test whether genetic, metabolic, epigenetic and brain-imaging patterns can help diagnose and guide care for people with Parkinson's disease, Alzheimer's disease, or type 2 diabetes.
-
Identifying protein biomarkers in biofluids for neurodegenerative disorders
This study is trying to find specific proteins in blood and other fluids that could help doctors diagnose and manage neurodegenerative diseases like Parkinson's and Alzheimer's earlier and better.
-
Understanding Inhibitory Neurotransmission in Drug-Resistant Epilepsy
This study is testing how certain brain receptors work in people with drug-resistant epilepsy to see if new treatments can help manage their condition better.
-
Effects of the Mediterranean diet on pregnancy and fetal development
This study is testing whether following the Mediterranean diet during pregnancy can improve outcomes for both mothers and their babies.
-
Identifying biomarkers of synaptic damage in multiple sclerosis
This study is testing blood and spinal fluid samples from people with multiple sclerosis to see if certain markers can help us understand brain changes and how the disease progresses.
Quick answers
How many clinical trials run by Neuromed IRCCS are recruiting right now?
6, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Italy. Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.